home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA During New (Drug) Development 2018

 
  July 25, 2018  
     
 
Netzealous LLC DBA - Compliance4All, Online
2018-09-07


Overview: 

Why is it important to engage with the FDA?

 

  • To discuss your development plan to support NDA or BLA regulatory submission
  • To identify and mitigate potential issues early
  • To identify any critical issues and aspects of your program such as
    • Preclinical studies
    • Chemistry, Manufacturing and Controls (CMC) Considerations
    • Clinical Studies
    • Pediatric considerations
    • Statistics or regulatory considerations

Why should you Attend: Provide guidance on effectively interacting with FDA throughout the new drug development process. 

Areas Covered in the Session:
  • Identify the major points of contact to engage with FDA's Center for Drug Evaluation and Research (CDER)
  • Describe the types of formal meetings that may be held with FDA
  • Understand different types of questions that may be asked during formal meetings
  • Outline the information needed to support such meetings
  • Explain how, when, and why to submit a meeting request and meeting package
  • Describe tips for productive meetings with FDA

Who Will Benefit:
  • Regulatory Affairs
  • Marketing Department
  • Compliance Specialists
  • Clinical Project Leaders

 
 
Organized by: Event Manager
Invited Speakers: Speaker Profile 
Angela Bazigos is the CEO of Touchstone Technologies Inc. She has degrees in Microbiology and Computing and 40 years of experience in the Life Sciences, Healthcare & Public Health Services. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety & Turnarounds. Past employers / clients include Royal Berkshire Hospital, Roche, Novartis, Genentech, PriceWaterhouseCoopers & Stanford Hospital. 
 
Deadline for Abstracts: 2018-09-06
 
Registration: https://www.compliance4all.com/control/w_product/~product_id=502109LIVE?channel=molgen_Sep_2018_SEO
E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.